1. The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis

   • John A. Kanis
   • Eugene V. McCloskey
   • Jean-Yves Reginster

   Position Paper 25 October 2022 Pages: 1 - 9

   

2. Doctors won’t treat patients for conditions they don’t have

   • Ian R. Reid

   Editorial 11 November 2022 Pages: 11 - 13

3. Exercise and the prevention of major osteoporotic fractures in adults: a systematic review and meta-analysis with special emphasis on intensity progression and study duration

   • Isabelle Hoffmann
   • Matthias Kohl
   • Wolfgang Kemmler

   Review Open access 10 November 2022 Pages: 15 - 28

   

4. Effectiveness of whole-body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials

   • Regina Dantas Jales de Oliveira
   • Raphael Gonçalves de Oliveira
   • Mario Bernardo-Filho

   Review 25 October 2022 Pages: 29 - 52

   

5. The relationship between sarcopenia-related measurements and osteoporosis: The SARCOP study

   • Tülay Tiftik
   • Murat Kara
   • Levent Özçakar

   Original Article 04 October 2022 Pages: 53 - 58

   

6. Frailty, length of stay and cost in hip fracture patients

   • Beatrix Ling Ling Wong
   • Yiong Huak Chan
   • Reshma Aziz Merchant

   Original Article 05 October 2022 Pages: 59 - 68

   

7. High rate of abdominal aortic calcification in COPD patients and its relationship with musculoskeletal fragility

   • Roberta Queiroz Graumam
   • Marcelo de Medeiros Pinheiro
   • Charlles Heldan de Moura Castro

   Original Article 27 October 2022 Pages: 69 - 79

   

8. Fracture risk in Parkinson’s disease according to its severity and duration

   • Hye Yeon Koo
   • Eun Bin Cho
   • Dong Wook Shin

   Original Article 07 October 2022 Pages: 81 - 89

   

9. Association of covert brain infarcts and white matter hyperintensities with risk of hip fracture in older adults: the Cardiovascular Health Study

   • Kerry M. Sheets
   • Petra Buzkova
   • Howard A. Fink

   Original Article 10 November 2022 Pages: 91 - 99

   

10. Tea consumption and the risks of osteoporosis and hip fracture: a population-based longitudinal follow-up study

    • Ya-Ping Huang
    • Li-Sheng Chen
    • Shin-Liang Pan

    Original Article Open access 14 October 2022 Pages: 101 - 109

    

11. Risk of major osteoporotic fractures among ultra-orthodox Jews

    • Merav Jacobson Bensky
    • Limor Adler
    • Yishai Mintzker

    Original Article Open access 11 November 2022 Pages: 111 - 118

    

12. Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study

    • Jinyoung Kim
    • Jeonghoon Ha
    • Ki-Hyun Baek

    Original Article 18 October 2022 Pages: 119 - 128

    

13. Should vertebral fracture assessment be performed in Fracture Liaison Service patients with non-vertebral fracture?

    • N. Binkley
    • J. T. Schousboe
    • W. D. Leslie

    Original Article 16 November 2022 Pages: 129 - 135

    

14. m2ABQ—a proposed refinement of the modified algorithm-based qualitative classification of osteoporotic vertebral fractures

    • H. L. Aaltonen
    • M. K. O’Reilly
    • N. M. Cross

    Original Article 07 November 2022 Pages: 137 - 145

    

15. Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy

    • Kim Phung
    • Laura McAdam
    • Leanne M. Ward

    Original Article 07 November 2022 Pages: 147 - 160

    

16. Pubertal increment in insulin resistance is negatively related to lumbar bone mineral density in 18-year-old males

    • Eva Mengel
    • Reeli Tamme
    • Vallo Tillmann

    Original Article 11 November 2022 Pages: 161 - 170

17. Proposed bone health screening protocol to identify total knee arthroplasty patients for preoperative DXA

    • Elliot Chang
    • Neil Binkley
    • Paul A. Anderson

    Original Article 03 November 2022 Pages: 171 - 177

    

18. Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women

    • Steven Fenwick
    • Vishal Vekariya
    • Akshaya Nath

    Original Article Open access 26 October 2022 Pages: 179 - 188

    

19. Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05

    • Satoshi Mori
    • Hiroshi Hagino
    • Satoshi Soen

    Original Article Open access 14 October 2022 Pages: 189 - 199

    

20. Long-term use of burosumab for the treatment of tumor-induced osteomalacia

    • C. Crotti
    • F. Zucchi
    • M. Varenna

    Short Communication 04 August 2022 Pages: 201 - 206

    

21. Prevalent vertebral fractures in patients admitted with acute hip fracture

    • Rajesh Dwivedi
    • Lalit Mishra
    • Opinder Sahota

    Letter to the Editor 07 November 2022 Pages: 207 - 208

22. Letter to the editor about the article “Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study”

    • Robin M. Daly
    • David Scott
    • Belinda R. Beck

    Letter to the Editor 15 November 2022 Pages: 209 - 210

23. Denosumab and muscle performance

    • Tim Rolvien
    • Tobias Rupp
    • Michael Amling

    Letter to the Editor Open access 15 November 2022 Pages: 211 - 212